Using preoperative UFT to predict sensitivity to fluoropyrimidines in colorectal cancer

ONCOLOGY

Volumn 13, Issue 7 SUPPL., 1999, Pages 55-60

  Fujii, Masashi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROPYRIMIDINE; OXALIPLATIN; TEGAFUR; URACIL;

ADULT; CANCER GRADING; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CONFERENCE PAPER; DOSE RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; SURVIVAL RATE;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLONOSCOPY; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; DRUG HYPERSENSITIVITY; FLUOROURACIL; HUMANS; NECROSIS; NEOPLASM STAGING; PREOPERATIVE CARE; PROSPECTIVE STUDIES; SURVIVAL RATE; TEGAFUR; TREATMENT OUTCOME; URACIL;

EID: 0032807086     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Pazdur R, Lassere Y, Rhodes V, et al : Phase II trial of uracil and tegafur plus oral leucovorin: An effective oral regimen in the treatment of metastatic colorectal carcinoma. J Clin Oncol 12:2296-2300, 1994.
2. Taguchi T: Experience with UFT in Japan. Oncology 11(suppl 10):30-34, 1997.
3. Kodaira S: Postoperative adjuvant chemotherapy with mitomycin C and UFT for rectal cancer. Oncology 11 (suppl 10):40-43, 1997.
4. Fujii M, Kochi M, Sawa H, et al: Preoperative and postoperative adjuvant chemotherapy for colorectal cancer (in Japanese). J Jpn Soc Cancer Ther 30:584-594, 1995.
5. Nakazato H, Koike A, Sail S, et al: Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: A prospective randomized trial (abstract). Proc Am Soc Clin Oncol 16:279, 1997.
6. Mitomi T, Tsuchiya S, Hiki Y, et al: A randomized, controlled study on adjuvant chemotherapy with UFT in curatively resected colorectal cancer (abstract). Proc Am Soc Clin Oncol 12:225, 1993.
7. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63, 1983.
8. Salmon S, Hamburger A, Soehnlen B, et al: Quantitation of differential sensitivity of human- tumor stem cells to anticancer drugs. N Engl J Med 298:1321-1327, 1978.
9. Becouarn Y, Ychou M, Ducruex M, et al: Oxaliplatin as first-line chemotherapy in metastatic colorectal patients: Preliminary activity/toxicity report (abstract 804). Proc Am Soc Clin Oncol 16:229, 1997.
10. Shimada Y, Yoshino M, Wakui A, et al: Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. J Clin Oncol 11:909-913, 1993.